| Devin Corrigan, MD | |
|
19260 Sw 65th Ave Ste 100, Tualatin, OR 97062-5702 | |
| (503) 691-2519 | |
| Not Available |
| Full Name | Devin Corrigan |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 19260 Sw 65th Ave Ste 100, Tualatin, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154958122 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MD214889 (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Devin Corrigan, MD 8645 Se Sunnybrook Blvd Ste 200, Clackamas, OR 97015-6841 Ph: () - | Devin Corrigan, MD 19260 Sw 65th Ave Ste 100, Tualatin, OR 97062-5702 Ph: (503) 691-2519 |
News Archive
Positron Corporation, a leading molecular imaging company specializing in the field of nuclear cardiology, announced the introduction of its automated radiopharmaceutical system, under the name PosiRx, at two upcoming industry conferences.
A common observation in oncology is the phenomenon that a patient with a tumor receives a drug and responds very well, but after a few months the cancer comes back and is now resistant to previously administered chemotherapy. What happened? Many mechanisms contribute to explain this effect called "acquired resistance", but today the group Manel Esteller, Director of Epigenetics and Cancer Biology at the Bellvitge Biomedical Research Institute, ICREA researcher and Professor of Genetics at the University of Barcelona, describes in the official Journal of the National Cancer Research Center in the United States, The Journal of The National Cancer Institute, the existence of epigenetic differences that explain the lack of response of the tumor recurs.
Relying on one of the largest collections of liver tissue samples ever acquired by a single organization, Geisinger Health System researchers have embarked on a massive study of one of the fastest growing liver problems.
When cancer patients take part in a clinical trial to develop new therapies, they and their physicians want to know how they will feel and function during treatment. A new collaboration between Bayer and The University of Texas MD Anderson Cancer Center will go straight to the patients to learn how certain investigational new drugs affect them.
› Verified 9 days ago
Dr. Laura K Murphy, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 19260 Sw 65th Ave Ste 340, Tualatin, OR 97062 Phone: 503-691-9777 Fax: 503-692-6736 | |
Kimberly Mersch Boyer, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 19260 Sw 65th Ave Ste 340, Tualatin, OR 97062 Phone: 971-272-4650 Fax: 503-692-6736 | |
Julie A Fiene Yeager, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 19260 Sw 65th Ave, Ste 340, Tualatin, OR 97062 Phone: 503-691-9777 Fax: 503-692-6736 | |
Magdalenne Marie Corso, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 19260 Sw 65th Ave, Ste 275, Tualatin, OR 97062 Phone: 503-691-2519 Fax: 503-659-8984 | |
Hilary Ann Wells, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 19185 Sw 90th Ave, Kaiser Permanente Tualatin Medical Office, Tualatin, OR 97062 Phone: 503-885-7300 | |
Robin Rae Leslie, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 19185 Sw 90th Ave, Tualatin, OR 97062 Phone: 503-885-7300 |